{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:28:19Z","timestamp":1792578499327,"version":"4.5.0"},"reference-count":101,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>Obesity is a worldwide epidemic with a future projected growth of 40% over 10 years. Obesity increases the risk of diabetes, hypertension, and cardiovascular disease, and it also leads to higher risk of CKD, through both direct and indirect mechanisms. Although obesity is a feature of overnutrition and is associated with poor outcomes in the general population, obese individuals with CKD often display complex metabolic patterns such as sarcopenic obesity, and obesity can be associated with better survival in individuals with advanced CKD. Weight loss interventions are proven to improve glycemic control and cardiovascular risk factors, and successful weight loss is associated with improved albuminuria in patients with preexisting CKD. The long-term effects of weight loss interventions on kidney function and on survival in patients with CKD are less well studied, and hence, such interventions should be individualized.<\/jats:p>","DOI":"10.2215\/cjn.0000000704","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T12:00:44Z","timestamp":1741953644000},"page":"742-754","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":27,"title":["Obesity and Metabolic Health in CKD"],"prefix":"10.2215","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8204-911X","authenticated-orcid":false,"given":"Csaba P.","family":"Kovesdy","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"issue":"1","key":"B1-20250512","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4102\/phcfm.v9i1.1435","article-title":"Obesity and kidney disease: hidden consequences of the epidemic","volume":"9","author":"Kovesdy","year":"2017","journal-title":"Afr J Prim Health Care Fam Med."},{"issue":"4","key":"B2-20250512","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","article-title":"Obesity-related glomerulopathy: an emerging epidemic","volume":"59","author":"Kambham","year":"2001","journal-title":"Kidney Int."},{"issue":"2","key":"B3-20250512","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.ajkd.2013.02.363","article-title":"Lifestyle-related factors, obesity, and incident microalbuminuria: the CARDIA (coronary artery risk development in young adults) study","volume":"62","author":"Chang","year":"2013","journal-title":"Am J Kidney Dis."},{"issue":"4","key":"B4-20250512","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0272-6386(03)00020-9","article-title":"A central body fat distribution is related to renal function impairment, even in lean subjects","volume":"41","author":"Pinto-Sietsma","year":"2003","journal-title":"Am J Kidney Dis."},{"issue":"9","key":"B5-20250512","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S2213-8587(15)00128-X","article-title":"Association of age and BMI with kidney function and mortality: a cohort study","volume":"3","author":"Lu","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7","key":"B6-20250512","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1681\/ASN.2021091263","article-title":"The association of excess body weight with risk of ESKD is mediated through insulin resistance, hypertension, and hyperuricemia","volume":"33","author":"Fritz","year":"2022","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B7-20250512","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ki.2009.137","article-title":"The link between obesity and albuminuria: adiponectin and podocyte dysfunction","volume":"76","author":"Sharma","year":"2009","journal-title":"Kidney Int."},{"key":"B8-20250512","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000095328","article-title":"Leptin and renal fibrosis","volume":"151","author":"Wolf","year":"2006","journal-title":"Contrib Nephrol."},{"issue":"4","key":"B9-20250512","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/HYPERTENSIONAHA.107.095257","article-title":"Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults","volume":"50","author":"Ellington","year":"2007","journal-title":"Hypertension."},{"issue":"1","key":"B10-20250512","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1681\/ASN.2020050679","article-title":"Conventional and genetic evidence on the association between adiposity and CKD","volume":"32","author":"Zhu","year":"2021","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B11-20250512","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/oby.22134","article-title":"Metabolically healthy obesity and risk of kidney function decline","volume":"26","author":"Chang","year":"2018","journal-title":"Obesity (Silver Spring)."},{"issue":"1","key":"B12-20250512","first-page":"4","article-title":"Recent advances in the relationship between obesity, inflammation, and insulin resistance","volume":"17","author":"Bastard","year":"2006","journal-title":"Eur Cytokine Netw."},{"issue":"12","key":"B13-20250512","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J Clin Invest."},{"issue":"12","key":"B14-20250512","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrneph.2009.184","article-title":"An update on the lipid nephrotoxicity hypothesis","volume":"5","author":"Ruan","year":"2009","journal-title":"Nat Rev Nephrol."},{"issue":"1","key":"B15-20250512","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semnephrol.2012.12.002","article-title":"The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases","volume":"33","author":"R\u00fcster","year":"2013","journal-title":"Semin Nephrol."},{"issue":"6","key":"B16-20250512","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/ndt\/gfm037","article-title":"Fasting insulin modifies the relation between age and renal function","volume":"22","author":"Oterdoom","year":"2007","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"B17-20250512","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","article-title":"Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease","volume":"2","author":"de Vries","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"B18-20250512","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1681\/ASN.V1261211","article-title":"Functional and structural changes in the kidney in the early stages of obesity","volume":"12","author":"Henegar","year":"2001","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B19-20250512","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/HYPERTENSIONAHA.107.099499","article-title":"Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet","volume":"51","author":"Knight","year":"2008","journal-title":"Hypertension."},{"issue":"8","key":"B20-20250512","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.ki.5002796","article-title":"Renal injury in the extremely obese patients with normal renal function","volume":"73","author":"Serra","year":"2008","journal-title":"Kidney Int."},{"issue":"3","key":"B21-20250512","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1681\/ASN.0000000000000294","article-title":"Renal mitochondrial ATP transporter ablation ameliorates obesity-induced CKD","volume":"35","author":"Permyakova","year":"2024","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B22-20250512","doi-asserted-by":"crossref","first-page":"F941","DOI":"10.1152\/ajprenal.00203.2019","article-title":"Obesity causes renal mitochondrial dysfunction and energy imbalance and accelerates chronic kidney disease in mice","volume":"317","author":"Andres-Hernando","year":"2019","journal-title":"Am J Physiol Renal Physiol."},{"issue":"4","key":"B23-20250512","doi-asserted-by":"crossref","first-page":"F491","DOI":"10.1152\/ajprenal.00113.2023","article-title":"Characterizing the metabolic response of the zebrafish kidney to overfeeding","volume":"325","author":"Zeitler","year":"2023","journal-title":"Am J Physiol Renal Physiol."},{"issue":"6","key":"B24-20250512","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/j.jrn.2018.08.006","article-title":"Global prevalence of protein-energy wasting in kidney disease: a meta-analysis of contemporary observational studies from the international society of renal nutrition and metabolism","volume":"28","author":"Carrero","year":"2018","journal-title":"J Ren Nutr."},{"issue":"4","key":"B25-20250512","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.ki.5002585","article-title":"A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease","volume":"73","author":"Fouque","year":"2008","journal-title":"Kidney Int."},{"issue":"2","key":"B26-20250512","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3945\/ajcn.2008.27390","article-title":"Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease","volume":"90","author":"Kovesdy","year":"2009","journal-title":"Am J Clin Nutr."},{"issue":"6","key":"B27-20250512","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3945\/ajcn.112.036418","article-title":"Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy","volume":"97","author":"Kovesdy","year":"2013","journal-title":"Am J Clin Nutr."},{"key":"B28-20250512","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1749-6632.2000.tb06498.x","article-title":"Body composition in healthy aging","volume":"904","author":"Baumgartner","year":"2000","journal-title":"Ann N Y Acad Sci."},{"issue":"3","key":"B29-20250512","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1152\/japplphysiol.00627.2006","article-title":"Sarcopenic obesity and inflammation in the InCHIANTI study","volume":"102","author":"Schrager","year":"2007","journal-title":"J Appl Physiol (1985)."},{"issue":"6","key":"B30-20250512","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1016\/j.clnu.2021.01.005","article-title":"Prevalence of sarcopenic obesity and sarcopenic overweight in the general population: the lifelines cohort study","volume":"40","author":"Wagenaar","year":"2021","journal-title":"Clin Nutr."},{"issue":"10","key":"B31-20250512","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/gerona\/gls071","article-title":"Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the fourth Korean National Health and Nutritional Examination Surveys","volume":"67","author":"Kim","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"7","key":"B32-20250512","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.2337\/dc10-0107","article-title":"Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA)","volume":"33","author":"Lim","year":"2010","journal-title":"Diabetes Care."},{"issue":"10","key":"B33-20250512","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/ndt\/gfv133","article-title":"Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality","volume":"30","author":"Pereira","year":"2015","journal-title":"Nephrol Dial Transplant."},{"issue":"6","key":"B34-20250512","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2008.638","article-title":"Factors other than glomerular filtration rate affect serum cystatin C levels","volume":"75","author":"Stevens","year":"2009","journal-title":"Kidney Int."},{"issue":"4","key":"B35-20250512","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.amjmed.2008.01.003","article-title":"Overweight, obesity, and elevated serum cystatin C levels in adults in the United States","volume":"121","author":"Muntner","year":"2008","journal-title":"Am J Med."},{"issue":"12","key":"B36-20250512","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.2215\/CJN.02140214","article-title":"Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States","volume":"9","author":"Sharma","year":"2014","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B37-20250512","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ekir.2016.10.008","article-title":"Sarcopenia, obesity, and mortality in US adults with and without chronic kidney disease","volume":"2","author":"Androga","year":"2017","journal-title":"Kidney Int Rep."},{"issue":"1","key":"B38-20250512","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s41100-019-0240-9","article-title":"Sarcopenic obesity and its association with frailty and protein-energy wasting in hemodialysis patients: preliminary data from a single center in Japan","volume":"5","author":"Saitoh","year":"2019","journal-title":"Ren Replace Ther."},{"key":"B39-20250512","doi-asserted-by":"crossref","first-page":"1342344","DOI":"10.3389\/fmed.2024.1342344","article-title":"Association between sarcopenic obesity and mortality in patients on peritoneal dialysis: a prospective cohort study","volume":"11","author":"Shen","year":"2024","journal-title":"Front Med (Lausanne)."},{"issue":"1","key":"B40-20250512","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/cells11010160","article-title":"Multifactorial mechanism of sarcopenia and sarcopenic obesity. Role of physical exercise, microbiota and myokines","volume":"11","author":"Bilski","year":"2022","journal-title":"Cells."},{"issue":"3","key":"B41-20250512","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41581-021-00498-0","article-title":"Pathophysiological mechanisms leading to muscle loss in chronic kidney disease","volume":"18","author":"Wang","year":"2022","journal-title":"Nat Rev Nephrol."},{"issue":"3","key":"B42-20250512","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/ageing\/afw214","article-title":"Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: the Concord Health and Ageing in Men Project","volume":"46","author":"Hirani","year":"2017","journal-title":"Age Ageing."},{"issue":"6","key":"B43-20250512","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/oby.20734","article-title":"Sarcopenic obesity and dynapenic obesity: 5-year associations with falls risk in middle-aged and older adults","volume":"22","author":"Scott","year":"2014","journal-title":"Obesity (Silver Spring)."},{"issue":"10","key":"B44-20250512","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/gerona\/glw327","article-title":"Clinical definitions of sarcopenia and risk of hospitalization in community-dwelling older men: the osteoporotic fractures in men study","volume":"72","author":"Cawthon","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"9","key":"B45-20250512","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ejcn.2014.117","article-title":"Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III","volume":"68","author":"Batsis","year":"2014","journal-title":"Eur J Clin Nutr."},{"issue":"1","key":"B46-20250512","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3945\/ajcn.117.152488","article-title":"Sarcopenic obesity, weight loss, and mortality: the English Longitudinal Study of Ageing","volume":"106","author":"Hamer","year":"2017","journal-title":"Am J Clin Nutr."},{"issue":"2","key":"B47-20250512","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcgg.2014.01.002","article-title":"Sarcopenia, but not sarcopenic obesity, predicts mortality for older old men: a 3-year prospective cohort study","volume":"5","author":"Liu","year":"2014","journal-title":"J Clin Gerontol Geriatr."},{"issue":"8","key":"B48-20250512","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ijo.2013.214","article-title":"Obesity and muscle strength as long-term determinants of all-cause mortality--a 33-year follow-up of the Mini-Finland Health Examination Survey","volume":"38","author":"Stenholm","year":"2014","journal-title":"Int J Obes (Lond)."},{"key":"B49-20250512","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000095319","article-title":"Obesity paradox in patients on maintenance dialysis","volume":"151","author":"Kalantar-Zadeh","year":"2006","journal-title":"Contrib Nephrol."},{"issue":"8","key":"B50-20250512","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/aje\/kwr384","article-title":"Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis","volume":"175","author":"Kalantar-Zadeh","year":"2012","journal-title":"Am J Epidemiol."},{"issue":"5","key":"B51-20250512","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1053\/j.ajkd.2007.02.277","article-title":"Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis","volume":"49","author":"Kovesdy","year":"2007","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"B52-20250512","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/HYPERTENSIONAHA.110.160747","article-title":"Diagnosing obesity by body mass index in chronic kidney disease: an explanation for the \u201cobesity paradox?\u201d","volume":"56","author":"Agarwal","year":"2010","journal-title":"Hypertension."},{"issue":"1","key":"B53-20250512","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000082012","article-title":"Reverse epidemiology: a spurious hypothesis or a hardcore reality?","volume":"23","author":"Kalantar-Zadeh","year":"2005","journal-title":"Blood Purif."},{"issue":"12","key":"B54-20250512","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.2215\/CJN.03790414","article-title":"Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study","volume":"9","author":"Wilson","year":"2014","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"B55-20250512","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/ajcn\/86.3.633","article-title":"Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality","volume":"86","author":"Honda","year":"2007","journal-title":"Am J Clin Nutr."},{"issue":"11","key":"B56-20250512","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4065\/mcp.2010.0336","article-title":"The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis","volume":"85","author":"Kalantar-Zadeh","year":"2010","journal-title":"Mayo Clin Proc."},{"issue":"8","key":"B57-20250512","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1111\/dom.14409","article-title":"Intensive management of obesity in people with severe chronic kidney disease: a review","volume":"23","author":"Song","year":"2021","journal-title":"Diabetes Obes Metab."},{"issue":"11","key":"B58-20250512","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.2215\/CJN.04010413","article-title":"Short-term changes after a weight reduction intervention in advanced diabetic nephropathy","volume":"8","author":"Friedman","year":"2013","journal-title":"Clin J Am Soc Nephrol."},{"issue":"8","key":"B59-20250512","doi-asserted-by":"crossref","first-page":"sfae217","DOI":"10.1093\/ckj\/sfae217","article-title":"Safety and efficacy of very low calorie diet in patients receiving haemodialysis therapy","volume":"17","author":"Woods","year":"2024","journal-title":"Clin Kidney J."},{"issue":"10120","key":"B60-20250512","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet."},{"issue":"4","key":"B61-20250512","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/nep.13680","article-title":"A practical guide for the use of very low calorie diets in adults with chronic kidney disease","volume":"25","author":"Lambert","year":"2020","journal-title":"Nephrology (Carlton)."},{"issue":"2","key":"B62-20250512","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2337\/dc15-1025","article-title":"Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, placebo-controlled, double-blind, parallel-group, randomized trial","volume":"39","author":"Idorn","year":"2016","journal-title":"Diabetes Care."},{"issue":"9","key":"B63-20250512","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"N Engl J Med."},{"issue":"1","key":"B64-20250512","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2009.09.011","article-title":"Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up","volume":"55","author":"MacLaughlin","year":"2010","journal-title":"Am J Kidney Dis."},{"issue":"11","key":"B65-20250512","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1681\/ASN.0000000512","article-title":"ASN kidney health guidance on the management of obesity in persons living with kidney diseases","volume":"35","author":"Ikizler","year":"2024","journal-title":"J Am Soc Nephrol."},{"issue":"18","key":"B66-20250512","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMc2410532","article-title":"Semaglutide for chronic kidney disease in type 2 diabetes. Reply","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med."},{"issue":"7","key":"B67-20250512","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/s41591-024-03015-5","article-title":"Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial","volume":"30","author":"Colhoun","year":"2024","journal-title":"Nat Med."},{"issue":"8","key":"B68-20250512","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2337\/dc23-0261","article-title":"Effects of tirzepatide versus insulin glargine on cystatin C-based kidney function: a SURPASS-4 post hoc analysis","volume":"46","author":"Heerspink","year":"2023","journal-title":"Diabetes Care."},{"issue":"1","key":"B69-20250512","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","volume":"13","author":"Badve","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"12","key":"B70-20250512","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1111\/dom.15967","article-title":"Semaglutide in patients with kidney failure and obesity undergoing dialysis and wishing to be transplanted: a prospective, observational, open-label study","volume":"26","author":"Vanek","year":"2024","journal-title":"Diabetes Obes Metab."},{"issue":"10","key":"B71-20250512","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.eprac.2024.07.008","article-title":"The use of semaglutide in patients with renal failure-A retrospective cohort study","volume":"30","author":"Long","year":"2024","journal-title":"Endocr Pract."},{"key":"B72-20250512","doi-asserted-by":"crossref","first-page":"101882","DOI":"10.1016\/j.eclinm.2023.101882","article-title":"Pharmacotherapy of obesity: an update on the available medications and drugs under investigation","volume":"58","author":"Chakhtoura","year":"2023","journal-title":"EClinicalMedicine."},{"issue":"2","key":"B73-20250512","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1681\/ASN.0000000000000271","article-title":"Effects of empagliflozin on fluid overload, weight, and blood pressure in CKD","volume":"35","author":"Mayne","year":"2024","journal-title":"J Am Soc Nephrol."},{"issue":"8","key":"B74-20250512","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2215\/CJN.01480219","article-title":"Trends in bariatric surgery procedures among patients with ESKD in the United States","volume":"14","author":"Sheetz","year":"2019","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"B75-20250512","first-page":"CD013119","article-title":"Interventions for weight loss in people with chronic kidney disease who are overweight or obese","volume":"3","author":"Conley","year":"2021","journal-title":"Cochrane Database Syst Rev."},{"issue":"4","key":"B76-20250512","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1681\/ASN.2018020176","article-title":"Bariatric surgery and kidney health","volume":"29","author":"Lieske","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B77-20250512","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.maturitas.2012.10.014","article-title":"\u02bbSarcobesity\u2019: a metabolic conundrum","volume":"74","author":"Parr","year":"2013","journal-title":"Maturitas."},{"issue":"3","key":"B78-20250512","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s40620-022-01553-0","article-title":"Muscle fat infiltration in chronic kidney disease: a marker related to muscle quality, muscle strength and sarcopenia","volume":"36","author":"Avesani","year":"2023","journal-title":"J Nephrol."},{"issue":"5","key":"B79-20250512","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MED.0000000000000279","article-title":"Mechanisms underpinning remission of albuminuria following bariatric surgery","volume":"23","author":"Nair","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"B80-20250512","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fendo.2020.00289","article-title":"Metabolic surgery to treat obesity in diabetic kidney disease, chronic kidney disease, and end-stage kidney disease; what are the unanswered questions?","volume":"11","author":"Martin","year":"2020","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"3","key":"B81-20250512","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clnu.2005.11.014","article-title":"The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up","volume":"25","author":"Serra","year":"2006","journal-title":"Clin Nutr."},{"issue":"10","key":"B82-20250512","doi-asserted-by":"crossref","first-page":"e0163907","DOI":"10.1371\/journal.pone.0163907","article-title":"Effects of bariatric surgery on renal function in obese patients: a systematic review and meta analysis","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One."},{"issue":"suppl 4","key":"B83-20250512","doi-asserted-by":"crossref","first-page":"iv82","DOI":"10.1093\/ndt\/gft302","article-title":"Effects of weight loss on renal function in obese CKD patients: a systematic review","volume":"28","author":"Bolignano","year":"2013","journal-title":"Nephrol Dial Transplant."},{"key":"B84-20250512","first-page":"1267","article-title":"Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons--a narrative review","volume":"10","author":"Goisser","year":"2015","journal-title":"Clin Interv Aging."},{"issue":"1","key":"B85-20250512","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2337\/db16-0607","article-title":"Renal and systemic effects of calorie restriction in patients with type 2 diabetes with abdominal obesity: a randomized controlled trial","volume":"66","author":"Ruggenenti","year":"2017","journal-title":"Diabetes."},{"key":"B86-20250512","doi-asserted-by":"crossref","first-page":"109804","DOI":"10.1016\/j.diabres.2022.109804","article-title":"Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial)","volume":"185","author":"Ruggenenti","year":"2022","journal-title":"Diabetes Res Clin Pract."},{"key":"B87-20250512","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.12659\/MSM.913512","article-title":"Long-term intensive lifestyle intervention promotes improvement of stage III diabetic nephropathy","volume":"25","author":"Dong","year":"2019","journal-title":"Med Sci Monit."},{"issue":"7","key":"B88-20250512","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med."},{"issue":"1","key":"B89-20250512","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dc19-0708","article-title":"Effect of surgical versus medical therapy on diabetic kidney disease over 5 years in severely obese adolescents with type 2 diabetes","volume":"43","author":"Bjornstad","year":"2020","journal-title":"Diabetes Care."},{"key":"B90-20250512","doi-asserted-by":"crossref","first-page":"101725","DOI":"10.1016\/j.eclinm.2022.101725","article-title":"Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial","volume":"53","author":"Cohen","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"1","key":"B91-20250512","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ijo.2014.72","article-title":"The incidence of albuminuria after bariatric surgery and usual care in Swedish Obese Subjects (SOS): a prospective controlled intervention trial","volume":"39","author":"Carlsson","year":"2015","journal-title":"Int J Obes (Lond)."},{"issue":"1","key":"B92-20250512","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.kint.2016.02.039","article-title":"Bariatric surgery is associated with improvement in kidney outcomes","volume":"90","author":"Chang","year":"2016","journal-title":"Kidney Int."},{"issue":"4","key":"B93-20250512","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2213-8587(17)30061-X","article-title":"Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study","volume":"5","author":"Carlsson","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"B94-20250512","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/j.ajkd.2016.09.020","article-title":"Estimated GFR before and after bariatric surgery in CKD","volume":"69","author":"Imam","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"B95-20250512","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1479164117742315","article-title":"Effect of bariatric surgery on diabetic nephropathy in obese type 2 diabetes patients in a retrospective 2-year study: a local pilot","volume":"15","author":"Chao","year":"2018","journal-title":"Diab Vasc Dis Res."},{"issue":"5","key":"B96-20250512","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41366-018-0045-x","article-title":"Incidence of end-stage renal disease following bariatric surgery in the Swedish Obese Subjects Study","volume":"42","author":"Shulman","year":"2018","journal-title":"Int J Obes (Lond)."},{"issue":"4","key":"B97-20250512","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1681\/ASN.2017060707","article-title":"Effect of bariatric surgery on CKD risk","volume":"29","author":"Friedman","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B98-20250512","doi-asserted-by":"crossref","first-page":"300","DOI":"10.7326\/M17-2383","article-title":"Microvascular outcomes in patients with diabetes after bariatric surgery versus usual care: a matched cohort study","volume":"169","author":"O'Brien","year":"2018","journal-title":"Ann Intern Med."},{"issue":"6","key":"B99-20250512","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2337\/dc19-1703","article-title":"Renal and cardiovascular outcomes after weight loss from gastric bypass surgery in type 2 diabetes: cardiorenal risk reductions exceed atherosclerotic benefits","volume":"43","author":"Liakopoulos","year":"2020","journal-title":"Diabetes Care."},{"issue":"3","key":"B100-20250512","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41366-020-00707-z","article-title":"Remission and progression of pre-existing micro- and macroalbuminuria over 15 years after bariatric surgery in Swedish Obese Subjects study","volume":"45","author":"Shulman","year":"2021","journal-title":"Int J Obes (Lond)."},{"issue":"3","key":"B101-20250512","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/SLA.0000000000006379","article-title":"Renoprotective effects of metabolic surgery versus GLP1 receptor agonists on progression of kidney impairment in patients with established kidney disease","volume":"280","author":"Aminian","year":"2024","journal-title":"Ann Surg."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:46Z","timestamp":1786369546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000000704","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]}}}